The BC Extracorporeal Cardiopulmonary Resuscitation Trial for Refractory Out-of-Hospital Cardiac Arrest
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 308
- 试验地点
- 5
- 主要终点
- Neurological Status will be assessed at hospital discharge using the Cerebral Performance Category scale
研究概览
简要总结
The addition of an Extracorporeal-Cardiopulmonary Resuscitation (ECPR) service to a region may improve the survival of young patients with sudden unexpected cardiac arrest.The primary aim of this study is to determine the benefit of the systematic integration of ECPR services into the out-of-hospital cardiac arrest management algorithm. The investigators will compare the outcomes of ECPR-eligible patients in the intervention region, in comparison to patients meeting the same criteria in a comparable setting.
详细描述
British Columbia is a province which contains four metropolitan areas, each of which contains at least one tertiary care centre that provides Extracorporeal Membrane Oxygenation (ECMO) and cardiovascular surgery services, in addition to critical cardiology services and a coronary catheterization laboratory. Pre-hospital medical care in all areas is provided by British Columbia Emergency Health Services (BCEHS), which uses a tiered system of basic life support and advanced life support (ALS) paramedics (90% of cases have ALS involvement) in coordination with fire department first responders. Medical providers in the study footprint have extensive experience with interventional trials enrolling patients with out-of-hospital cardiac arrest, through participation in the Resuscitation Outcomes Consortium.
Through collaboration of clinicians from all areas and with BCEHS, this study will examine the benefit of a regional ECPR protocol established in one of the metropolitan areas (the "ECPR Protocol Region"), in comparison to the other areas (the "Usual Care Region"). The primary aim is to determine the benefit of incorporating ECPR services into a regional medical system of care for out-of-hospital cardiac arrest. All patients with out-of-hospital cardiac arrest treated by emergency medical services (EMS) in both regions will be prospectively evaluated for study eligibility.
Secondary aims include:
- To evaluate the effectiveness of ECPR therapy for those with refractory cardiac arrest after 45 minutes of attempted resuscitation.
- To evaluate the effectiveness of a regional ECPR protocol, in comparison to historical controls.
- To evaluate the long-term (5-year) outcomes of patients treated with ECPR.
- To evaluate the quantity of successful organ procurement from those treated with ECPR.
- To evaluate the cost-effectiveness of a regional ECPR protocol.
This study is a parallel group design with group allocation based on region of treatment. The investigators will compare the outcomes of ECPR-eligible patients in the intervention region, in comparison to patients meeting the same criteria in a comparable setting (the control regions group). Medical care in the control regions will be unaltered by this study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Intra-arrest treatment by an ALS paramedic
- •Age ≥ 18 and ≤ 65 years
- •Witnessed arrest
- •Bystander CPR required if initial rhythm is pulseless electrical activity (added to the protocol June, 2018 and applied retrospectively)
- •Cause of the arrest is presumed to be one of the following:
- •No obvious non-cardiac cause is identified
- •Known overdose of one of the following drugs: beta-blocker, calcium channel blocker, tricyclic antidepressants or other psychiatric medications, or digoxin
- •Hypothermia (with T < 32°C)
- •(5) The patient remains pulseless after a minimum of 3 cycles of CPR (by any professional provider).
排除标准
- •An alternate cause of the arrest is most likely
- •Do Not Resuscitate status
- •Co-morbidities including congestive heart failure, chronic obstructive pulmonary disease or other significant lung disease, dialysis, liver failure (if co-morbidities are unknown to paramedics they will be assumed not present)
- •Active malignancy
- •Pre-existing major neurological deficit
- •Asystole (added to the protocol June, 2018 and applied retrospectively)
结局指标
主要结局
Neurological Status will be assessed at hospital discharge using the Cerebral Performance Category scale
时间窗: Patients will be followed from the time of cardiac arrest until death or hospital discharge, up to 6 months.
Cerebral Performance Categories 1 and 2 will be considered favourable outcomes. Adjudication for these outcomes will be assessed with a structured algorithm via chart review blinded to treatment group.
次要结局
- Survival will be assessed at hospital discharge(Patients will be followed from the time of cardiac arrest until death or hospital discharge, up to 6 months.)
研究者
Brian Grunau
Assistant Professor
University of British Columbia